Pharmaceutical giant Eli Lilly alleges the companies are selling off-brand versions of its best-selling diabetes and weight-loss drugs, Mounjaro and Zepbound.
Več na: https://www.wired.com/story/glp-1-compounding-fda-lawsuits/
nazaj
